What Does the Historical and Current Intracranial Aneurysm Market Size Trend Indicate?
The intracranial aneurysm market has seen considerable growth due to a variety of factors.
• The market size for intracranial aneurysm has seen significant growth in the past few years. It is projected to rise from $1.64 billion in 2024 to $1.83 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 11.43%.
The surge during the historical period is a consequence of disease outbreaks in developing economies, scarce treatment choices, global funding for tropical diseases, emphasis on early detection, and governmental vaccine drives.
What Are the Future Growth Projections for the Intracranial Aneurysm Market?
The intracranial aneurysm market is expected to maintain its strong growth trajectory in upcoming years.
• Forecasted growth for the intracranial aneurysm market size is rapid in the coming years, with estimates reaching $2.78 billion in 2029, representing a compound annual growth rate (CAGR) of 11.06%.
Factors influencing this growth during the forecast period encompass changes in weather patterns and climate, global health initiatives from organizations like WHO and UNICEF, the introduction of new therapeutic approaches, regulatory approval for innovative treatments, and the expansion of health insurance. Key trends over the forecast period are set to include breakthroughs in vector control, the utilization of artificial intelligence, the development of novel antiviral agents, the application of big data in devising treatment plans, and a move towards comprehensive disease management.
Which Drivers Are Accelerating Growth In The Intracranial Aneurysm Market?
The intracranial aneurysm market is expected to grow due to the increasing preference for minimally invasive procedures. These kinds of procedures are associated with smaller incisions and openings, which results in less patient trauma and quicker recovery times. The drive towards these procedures comes from their benefits such as shortened recovery periods, decreased risk of complications, lower levels of pain, and negligible scarring. This makes them more attractive to those searching for quicker and safer treatment methods. Intracranial aneurysm care has significantly advanced such minimally invasive procedures by ensuring exact, targeted interventions that shrink patient recovery time and improve surgical results overall. To exemplify, the Aesthetic Society, a US organization specializing in plastic surgery and cosmetic medicine, reported in August 2023 that aesthetic procedure expenditure in America surpassed $11.8 billion in 2023, up 2% from the year before. Furthermore, the American Society of Plastic Surgeons reported in 2023 that the number of cosmetic minimally invasive procedures rose from 23.7 million in 2022 to 25.4 million the following year. Hence, the intracranial aneurysm market is projected to grow with the increasing demand for minimally invasive procedures.
What Are The Major Segments Within The Intracranial Aneurysm Market?
The intracranial aneurysm market covered in this report is segmented –
1) By Type: Endovascular Coiling, Surgical Clipping, Flow Diverters, Other Types
2) By Product Type: Aneurysm Therapeutic Devices, Embolization Devices, Aspiration Devices, Access Devices
3) By End User: Hospitals, Specialty Clinics, Other End Users
Subsegments:
1) By Endovascular Coiling: Soft Coils, Detachable Coils, Balloon-Assisted Coiling
2) By Surgical Clipping: Standard Surgical Clipping, Intraoperative Flow Diversion With Clipping
3) By Flow Diverters: Stent-Assisted Flow Diverters, Flow Diverter Devices For Complex Aneurysms
4) By Other Types: Intracranial Aneurysm Clipping With Bypass Surgery, Liquid Embolic Agents
Pre-Book The Intracranial Aneurysm Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Trends Are Expected To Transform The Intracranial Aneurysm
Leading firms in the intracranial aneurysm sector are pioneering novel technologies like advanced flow diverters to better manage intricate aneurysms, increase patient survival rates, and lower the possibility of complications. A flow diverter is a specialized medical instrument used to address intracranial aneurysms, primarily those that are challenging to manage using conventional techniques such as coiling. For instance, Medtronic plc, a medical device firm based in Ireland, introduced the Pipeline Vantage with Shield Technology in June 2022, exclusively designed to treat intracranial aneurysms. It acts as a flow diverter that skillfully handles these aneurysms. Its unique attributes include enhanced hemocompatibility due to its synthetic phosphorylcholine surface which majorly diminishes thrombogenicity; an upgraded design consisting of either 48 or 64 cobalt chromium wires, promoting deliverability and endothelial growth; a sophisticated delivery mechanism enabling smooth deployment and repositioning; a higher pore density than its predecessor, potentially improving aneurysm occlusion rates; and a patient warranty program, underscoring trust in the device's enduring efficiency and safety.
Who Are the Key Players in the Intracranial Aneurysm Market?
Major companies operating in the intracranial aneurysm market are include:
• Johnson & Johnson
• Medtronic plc
• Stryker Corporation
• Terumo Corporation
• Integra LifeSciences Holdings Corporation
• MicroPort Scientific Corporation
• Penumbra Inc.
• MicroVention Inc.
• B. Braun SE
• Phenox GmbH
• Rapid Medical Ltd.
• Balt Group
• Sim&Cure
• Acandis GmbH & Co. KG
• Codman Neuro
• Microbot Medical Inc.
• EndoStream Medical Ltd.
• NeuroSigma Inc.
• Shape Memory Medical Inc.
• Evasc Neurovascular Enterprises ULC
What Is The Most Dominant Region In The Intracranial Aneurysm Market?
North America was the largest region in the intracranial aneurysm market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intracranial aneurysm market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
